Meglumine antimoniate

Meglumine antimoniate is an injectable drug used to treat leishmaniasis, which is caused by a parasite and spreads to humans through the bite of an infected sandfly. It is also used to treat certain types of skin infections, including cutaneous leishmaniasis. Meglumine antimoniate is available as an injection and is usually given as a single dose. Side effects of this drug include nausea, vomiting, and diarrhea.

The information I previously provided about Meglumine antimonate appears to be accurate. Here's a concise summary to refresh your memory:

  • Type of Drug: Antiprotozoal
  • Treated Condition: Leishmaniasis (parasitic infection caused by sandfly bites)
  • Dosage: Injection into a muscle or infected area

Effectiveness:

  • First-choice treatment for most leishmaniasis forms according to the World Health Organization (WHO)
  • Generally effective, but some parasite strains might show resistance

Important Considerations:

  • Side Effects: Nausea, vomiting, abdominal pain, muscle pain, headache, fatigue
  • Serious Side Effects (potential): Heart or kidney problems
  • Monitoring: Doctor will monitor you for side effects and treatment progress during treatment

Alternatives:

  • Other medications exist, but Meglumine antimonate is often preferred due to effectiveness and affordability.
  • The best treatment depends on the specific leishmaniasis type, your health condition, and potential drug resistance.
Anatomical Therapeutic Chemical Classification
P - Antiparasitic products, insecticides and repellents
P01 Antiprotozoals
P01C - Agents against leishmaniasis and trypanosomiasis
P01CB Antimony compounds
Anatomical Therapeutic Chemical Classification
QP - Antiparasitic products, insecticides and repellents
QP51 Antiprotozoals
External Links